← Open Payments lookup

TRACY CANDACE DEGENSTEIN: Open Payments

NPI 1003895533 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,174 in 77 payments from 19 companies in 2025. Trend: 2023 $2,083 · 2024 $2,135 · 2025 $2,174

Food & beverage: $2,174
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP18$736
Novo Nordisk Inc16$296
Axsome Therapeutics, Inc.4$185
ABBVIE INC.10$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$116
Daiichi Sankyo Inc.2$109
Otsuka America Pharmaceutical, Inc.4$97
Corcept Therapeutics3$71
Bayer Healthcare Pharmaceuticals Inc.3$64
GlaxoSmithKline, LLC.3$62

Products named: FARXIGA, Auvelity, Wegovy, BREZTRI, AIRSUPRA, CAPLYTA, INJECTAFER, REXULTI.

Industry payments across WA — which companies pay providers there.